Articles

A team, led by Matthias von Herrath, M.D., an internationally recognized expert on the molecular basis of type 1 diabetes, used a combinatorial treatment approach in laboratory mice and found it reversed recent onset type 1 diabetes in the majority of animals tested.

Researchers have shown, for the first time, that blocking the action of a critical protein with etanercept can improve multiple inflammatory pathways in patients with the metabolic syndrome and Type 2 diabetes.

An increase in diabetes of 41% in just 6 years and it is projected to get much worse with nothing in place to stop it!

Researchers have now carefully crafted a combination therapy that reverses recent-onset type 1 diabetes.

By adding a small dose (25mg) of spironolactone to the treatment of patients with type 2 diabetes and albuminuria, a 26% drop was seen for those with microalbumuria and a 20.8% drop for those with macroalbuminuria.

Gonadotropin-releasing hormone (GnRH) agonist treatment for prostate cancer appears to increase the chances of diabetes development, according to Boston-based researchers.

The ratio of albumin to creatinine in random urine samples can be used to identify pregnant women with type 1 diabetes who have microalbuminuria.

The prevalence of diabetes is significantly higher in patients with schizophrenia or schizoaffective disorder relative to the general population — irrespective of the use of, or type of, antipsychotic medication.

The fibric acid derivative bezafibrate effectively attenuates the progression of insulin resistance in patients with coronary artery disease.Glycemic Control Cuts

Comparison of Breakfast and Bedtime Insulin Glargine in Children and Adolescents with Type 1 DiabetesOnce-daily dose of insulin glargine at breakfast in children and adolescents with Type 1 diabetes on intensive therapy is more efficacious than bedtime administration.